Correction of Metabolic Disorders and Its Effect on Respiratory Function of Lungs in Patients With Severe COVID-19
- Conditions
- COVID-19
- Interventions
- Drug: ReamberinDrug: Ringer's solution
- First Posted Date
- 2021-12-29
- Last Posted Date
- 2024-12-19
- Target Recruit Count
- 105
- Registration Number
- NCT05172180
- Locations
- 🇷🇺
Nizhegorodskaya Regional Clinical Hospital named after N.A. Semashko, Nizhny Novgorod, Russian Federation
Meglimine Sodium Succinate for Correction of Metabolic Acidosis in Critically Ill Patients
- Conditions
- Metabolic Acidosis
- Interventions
- Drug: PlaceboDrug: Meglumine Sodium Succinate
- First Posted Date
- 2021-12-07
- Last Posted Date
- 2022-10-05
- Target Recruit Count
- 140
- Registration Number
- NCT05147051
- Locations
- 🇷🇺
Ivanovo Regional Clinical Hospital, Ivanovo, Russian Federation
🇷🇺Central Clinical Hospital with a polyclinic of the Office of the President of the Russian Federation, Moscow, Russian Federation
🇷🇺GBUZ Arkhangelsk region "First GKB named after E.E. Volosevich", Arkhangel'sk, Russian Federation
Cytoflavin in the Treatment of Patients With Diabetic Polyneuropathy
- Conditions
- Diabetic Neuropathies
- Interventions
- Drug: PlaceboDrug: Cytoflavin (Inosine + Nicotinamide + Riboflavin + Succinic Acid)
- First Posted Date
- 2020-12-02
- Last Posted Date
- 2023-01-27
- Target Recruit Count
- 216
- Registration Number
- NCT04649203
- Locations
- 🇷🇺
City Outpatient Clinic #51, Saint Petersburg, Russian Federation
🇷🇺North-West State Medical University named after I.I. Mechnikov, Saint Petersburg, Russian Federation
🇷🇺City Outpatient Clinic #117, Saint-Petersburg, Russian Federation
International Trial of Efficacy of Cytoflavin in Head Trauma
- Conditions
- Head Trauma,Closed
- Interventions
- First Posted Date
- 2020-11-17
- Last Posted Date
- 2024-09-30
- Target Recruit Count
- 166
- Registration Number
- NCT04631484
- Locations
- 🇰🇿
West Kazakhstan Medical University named after. M. Ospanov, Aktobe, Actobe, Kazakhstan, Kazakhstan
🇷🇺Ivanovskaya Regional Clinical Hospital, Ivanovo, Russian Federation
🇷🇺City Clinical Hospital No. 67 named after L.A. Vorokhobov, Moscow, Russian Federation
Cytoflavin in the Rehabilitation of Post-intensive Care Syndrome in Stroke Survivors
- Conditions
- Ischemic StrokePost Intensive Care Unit Syndrome
- First Posted Date
- 2019-12-11
- Last Posted Date
- 2024-07-19
- Target Recruit Count
- 60
- Registration Number
- NCT04194229
- Locations
- 🇷🇺
Brain Institute Clinic, Ekaterinburg, Sverdlovsk Region, Russian Federation
"Unifuzol®" in Patients With Peripheral Arterial Disease
- Conditions
- Peripheral Arterial Disease
- Interventions
- First Posted Date
- 2019-03-04
- Last Posted Date
- 2020-01-31
- Target Recruit Count
- 360
- Registration Number
- NCT03861416
- Locations
- 🇷🇺
Orenburg Regional Clinical Hospital, Orenburg, Russian Federation
🇷🇺St. Petersburg State Medical University n.a. I.P.Pavlov, Saint Petersburg, Russian Federation
🇷🇺National Medical Research Center named after Academician E.N. Meshalkin, Novosibirsk, Russian Federation
Efficacy and Safety of Cytoflavin® Used in Elderly Patients for the Prevention of Cognitive Decline After Major Surgery
- Conditions
- Cognitive Dysfunction
- Interventions
- Drug: Cytoflavin® solutionDrug: Placebo solutionDrug: Placebo enteric-coated tabletDrug: Cytoflavin® enteric-coated tablet
- First Posted Date
- 2019-02-21
- Last Posted Date
- 2023-01-31
- Target Recruit Count
- 200
- Registration Number
- NCT03849664
- Locations
- 🇷🇺
Regional Clinical Hospital № 3, Chelyabinsk, Russian Federation
🇷🇺Central Clinical Hospital with a polyclinic of the Office of the President of the Russian Federation, Moscow, Russian Federation
🇷🇺Alexandrovskaya City Hospital, Saint Petersburg, Russian Federation
Remaxol® in Mechanical Jaundice of Non-malignant Origin
- Conditions
- Jaundice, Obstructive
- Interventions
- Drug: Remaxol (succinate + methionine + inosine + nicotinamide)Drug: Ringer's Solution
- First Posted Date
- 2018-02-01
- Last Posted Date
- 2020-07-14
- Target Recruit Count
- 342
- Registration Number
- NCT03418935
- Locations
- 🇷🇺
Moscow 'City Clinical Hospital #24, Moscow, Russian Federation
🇷🇺Moscow City Clinical Hospital #1 n.a.N.I.Pirogov, Moscow, Russian Federation
🇷🇺Moscow City Clinical Hospital #29 n.a.N.A.Bauman, Moscow, Russian Federation
Remaxol® in Malignant Mechanical Jaundice
- Conditions
- Jaundice; Malignant
- Interventions
- Drug: Ringer's SolutionDrug: Remaxol®
- First Posted Date
- 2018-01-30
- Last Posted Date
- 2020-07-10
- Target Recruit Count
- 240
- Registration Number
- NCT03416062
- Locations
- 🇷🇺
City Clinical Hospital of Emergency Care, Ryazan, Russian Federation
🇷🇺SPb GBUZ 'City Mariinskaya Hospital', Saint Petersburg, Russian Federation
🇷🇺Omsk Regional Clinical Oncology Center, Omsk, Russian Federation
Study of Safety and Tolerability of UNIFUZOL (Solution for Infusions) in Healthy Volunteers
- First Posted Date
- 2017-01-23
- Last Posted Date
- 2020-07-14
- Target Recruit Count
- 48
- Registration Number
- NCT03028285
- Locations
- 🇷🇺
Clinical diagnostic laboratory of City Clinical Hospital named after I.V.Davydovsky, Moscow, Russian Federation
🇷🇺Research Center for Eco-safety, Ltd., Saint Petersburg, Russian Federation